Salt Capital, a private equity investment firm focused on growth capital investments in the SADC region, and Proparco, the French Development finance institution, have acquired The Namibian Oncology Centre (NOC), a specialist cancer care provider in Namibia.
“By supporting The Namibian Oncology Centre, we are contributing to expanding access to high-quality oncology care and strengthening cancer awareness,” said Johann Choux, regional director – Southern Africa and Indian Ocean at Proparco.
Founded by Namibian clinicians, healthcare professionals and local business people, NOC has played a pivotal role in advancing access to cancer diagnosis, treatment, and care in the country. It will continue to operate as an independent specialist provider, under its existing management team, with Stephanie Quarmby continuing as managing director.
Salt Capital and Proparco’s role will be that of a long-term, supportive shareholder, focused on strengthening governance, sustainability, and healthcare standards, while preserving the centre’s clinical autonomy and culture of care.
“The Namibian Oncology Centre plays a critical role in the country’s healthcare ecosystem,” said Jan Bosch, managing partner of Salt Capital. “Our focus is on supporting the centre’s mission, strengthening healthcare standards, and contributing meaningfully to cancer awareness and access to care in Namibia.”
Engling, Stritter & Partners (James Smith, Daneale Beukes, Axel Stritter) advised on the transaction.
Press release: Salt Capital and Proparco Announce the acquisition of The Namibian Oncology Centre | Salt Capital
